标题
Novel targets in the treatment of chronic graft-versus-host disease
作者
关键词
-
出版物
LEUKEMIA
Volume 31, Issue 3, Pages 543-554
出版商
Springer Nature
发表日期
2016-11-30
DOI
10.1038/leu.2016.367
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Antibodies from donor B cells perpetuate cutaneous chronic graft-versus-host disease in mice
- (2016) H. Jin et al. BLOOD
- Preclinical models of acute and chronic graft-versus-host disease: how predictive are they for a successful clinical translation?
- (2016) R. Zeiser et al. BLOOD
- Targeted Rho-associated kinase 2 inhibition suppresses murine and human chronic GVHD through a Stat3-dependent mechanism
- (2016) R. Flynn et al. BLOOD
- Efficacy, durability, and response predictors of low-dose interleukin-2 therapy for chronic graft-versus-host disease
- (2016) John Koreth et al. BLOOD
- Imatinib and dasatinib as salvage therapy for sclerotic chronic graft-vs-host disease
- (2016) Isabel Sánchez-Ortega et al. CROATIAN MEDICAL JOURNAL
- Thymus: the next (re)generation
- (2016) Mohammed S. Chaudhry et al. IMMUNOLOGICAL REVIEWS
- Phase II Multicenter, Randomized, Double-Blind Controlled Study of Efficacy and Safety of Umbilical Cord–Derived Mesenchymal Stromal Cells in the Prophylaxis of Chronic Graft-Versus-Host Disease After HLA-Haploidentical Stem-Cell Transplantation
- (2016) Lei Gao et al. JOURNAL OF CLINICAL ONCOLOGY
- Upregulation of IFN-Inducible and Damage-Response Pathways in Chronic Graft-versus-Host Disease
- (2016) Frances T. Hakim et al. JOURNAL OF IMMUNOLOGY
- Oral Ixazomib, Lenalidomide, and Dexamethasone for Multiple Myeloma
- (2016) Philippe Moreau et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ponesimod, a selective S1P1 receptor modulator: a potential treatment for multiple sclerosis and other immune-mediated diseases
- (2016) Daniele D’Ambrosio et al. Therapeutic Advances in Chronic Disease
- National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: VI. The 2014 Clinical Trial Design Working Group Report
- (2015) Paul J. Martin et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- A Bortezomib-Based Regimen Offers Promising Survival and Graft-versus-Host Disease Prophylaxis in Myeloablative HLA-Mismatched and Unrelated Donor Transplantation: A Phase II Trial
- (2015) John Koreth et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: III. The 2014 Biomarker Working Group Report
- (2015) Sophie Paczesny et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Ofatumumab in Combination with Glucocorticoids for Primary Therapy of Chronic Graft-versus-Host Disease: Phase I Trial Results
- (2015) Joseph Pidala et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- B Cells in Chronic Graft-versus-Host Disease
- (2015) Stefanie Sarantopoulos et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Increasing Incidence of Chronic Graft-versus-Host Disease in Allogeneic Transplantation: A Report from the Center for International Blood and Marrow Transplant Research
- (2015) Sally Arai et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Measuring Therapeutic Response in Chronic Graft-versus-Host Disease. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. The 2014 Response Criteria Working Group Report
- (2015) Stephanie J. Lee et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report
- (2015) Madan H. Jagasia et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Targeting Syk-activated B cells in murine and human chronic graft-versus-host disease
- (2015) R. Flynn et al. BLOOD
- Aberrant B-cell homeostasis in chronic GVHD
- (2015) S. Sarantopoulos et al. BLOOD
- The novel mechanism of lenalidomide activity
- (2015) E. C. Fink et al. BLOOD
- Umbilical cord blood-derived T regulatory cells to prevent GVHD: kinetics, toxicity profile, and clinical effect
- (2015) C. G. Brunstein et al. BLOOD
- Childhood to adult transition and long-term follow-up after blood and marrow transplantation
- (2015) M C Cupit et al. BONE MARROW TRANSPLANTATION
- Pharmacologic Inhibition of JAK1/JAK2 Signaling Reduces Experimental Murine Acute GVHD While Preserving GVT Effects
- (2015) C. Carniti et al. CLINICAL CANCER RESEARCH
- A Randomized Phase II Crossover Study of Imatinib or Rituximab for Cutaneous Sclerosis after Hematopoietic Cell Transplantation
- (2015) S. Arai et al. CLINICAL CANCER RESEARCH
- Outcomes of acute leukemia patients transplanted with naive T cell–depleted stem cell grafts
- (2015) Marie Bleakley et al. JOURNAL OF CLINICAL INVESTIGATION
- Ruxolitinib in corticosteroid-refractory graft-versus-host disease after allogeneic stem cell transplantation: a multicenter survey
- (2015) R Zeiser et al. LEUKEMIA
- Modern approaches to HLA-haploidentical blood or marrow transplantation
- (2015) Christopher G. Kanakry et al. Nature Reviews Clinical Oncology
- Carfilzomib, Lenalidomide, and Dexamethasone for Relapsed Multiple Myeloma
- (2015) A. Keith Stewart et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inhibition of BTK and ITK with Ibrutinib Is Effective in the Prevention of Chronic Graft-versus-Host Disease in Mice
- (2015) Steven D. Schutt et al. PLoS One
- A Phase II Study of Bortezomib Plus Prednisone for Initial Therapy of Chronic Graft-versus-Host Disease
- (2014) Alex F. Herrera et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Treatment of chronic graft-versus-host disease with bortezomib
- (2014) C.-C. S. Pai et al. BLOOD
- Increased BCR responsiveness in B cells from patients with chronic GVHD
- (2014) Jessica L. Allen et al. BLOOD
- Activity of therapeutic JAK 1/2 blockade in graft-versus-host disease
- (2014) S. Spoerl et al. BLOOD
- Current issues in chronic graft-versus-host disease
- (2014) G. Socie et al. BLOOD
- Ibrutinib treatment ameliorates murine chronic graft-versus-host disease
- (2014) Jason A. Dubovsky et al. JOURNAL OF CLINICAL INVESTIGATION
- Blockade of Syk ameliorates the development of murine sclerodermatous chronic graft-versus-host disease
- (2014) Doanh Le Huu et al. JOURNAL OF DERMATOLOGICAL SCIENCE
- Oral ponesimod in relapsing-remitting multiple sclerosis: a randomised phase II trial
- (2014) T. Olsson et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Pharmacologic Blockade of JAK1/JAK2 Reduces GvHD and Preserves the Graft-Versus-Leukemia Effect
- (2014) Jaebok Choi et al. PLoS One
- Bronchoalveolar Lavage as a Tool to Predict, Diagnose and Understand Bronchiolitis Obliterans Syndrome
- (2013) V. E. Kennedy et al. AMERICAN JOURNAL OF TRANSPLANTATION
- FTY720 Ameliorates Murine Sclerodermatous Chronic Graft-Versus-Host Disease by Promoting Expansion of Splenic Regulatory Cells and Inhibiting Immune Cell Infiltration Into Skin
- (2013) Doanh Le Huu et al. ARTHRITIS AND RHEUMATISM
- National Institutes of Health Chronic Graft-versus-Host Disease Staging in Severely Affected Patients: Organ and Global Scoring Correlate with Established Indicators of Disease Severity and Prognosis
- (2013) Kristin Baird et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- In Vivo T Cell Costimulation Blockade with Abatacept for Acute Graft-versus-Host Disease Prevention: A First-in-Disease Trial
- (2013) Divya T. Koura et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- The JAK-inhibitor ruxolitinib impairs dendritic cell function in vitro and in vivo
- (2013) A. Heine et al. BLOOD
- Rituximab prophylaxis prevents corticosteroid-requiring chronic GVHD after allogeneic peripheral blood stem cell transplantation: results of a phase 2 trial
- (2013) C. Cutler et al. BLOOD
- JAKs and STATs in Immunity, Immunodeficiency, and Cancer
- (2013) John J. O'Shea et al. NEW ENGLAND JOURNAL OF MEDICINE
- H-Y antigen-binding B cells develop in male recipients of female hematopoietic cells and associate with chronic graft vs. host disease
- (2013) B. Sahaf et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Phase II study of a neutrophil elastase inhibitor (AZD9668) in patients with bronchiectasis
- (2013) Robert Stockley et al. RESPIRATORY MEDICINE
- Combined Inhibition of c-Abl and PDGF Receptors for Prevention and Treatment of Murine Sclerodermatous Chronic Graft-versus-Host Disease
- (2012) Pawel Zerr et al. AMERICAN JOURNAL OF PATHOLOGY
- Inhibition of hedgehog signalling prevents experimental fibrosis and induces regression of established fibrosis
- (2012) Angelika Horn et al. ANNALS OF THE RHEUMATIC DISEASES
- Prophylactic rituximab after allogeneic transplantation decreases B-cell alloimmunity with low chronic GVHD incidence
- (2012) S. Arai et al. BLOOD
- Inhibition of hedgehog signaling for the treatment of murine sclerodermatous chronic graft-versus-host disease
- (2012) P. Zerr et al. BLOOD
- IFN R signaling mediates alloreactive T-cell trafficking and GVHD
- (2012) J. Choi et al. BLOOD
- Efficacy, safety and effect on biomarkers of AZD9668 in cystic fibrosis
- (2012) J. Stuart Elborn et al. EUROPEAN RESPIRATORY JOURNAL
- Bortezomib-Based Graft-Versus-Host Disease Prophylaxis in HLA-Mismatched Unrelated Donor Transplantation
- (2012) John Koreth et al. JOURNAL OF CLINICAL ONCOLOGY
- A Double-Blind, Placebo-Controlled Trial of Ruxolitinib for Myelofibrosis
- (2012) Srdan Verstovsek et al. NEW ENGLAND JOURNAL OF MEDICINE
- Donor B-cell alloantibody deposition and germinal center formation are required for the development of murine chronic GVHD and bronchiolitis obliterans
- (2011) M. Srinivasan et al. BLOOD
- Patient-reported quality of life is associated with severity of chronic graft-versus-host disease as measured by NIH criteria: report on baseline data from the Chronic GVHD Consortium
- (2011) J. Pidala et al. BLOOD
- Global and organ-specific chronic graft-versus-host disease severity according to the 2005 NIH Consensus Criteria
- (2011) S. Arai et al. BLOOD
- Rituximab for prevention and treatment of graft-versus-host disease
- (2011) Mohamed A. Kharfan-Dabaja et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Long-Term Survival and Late Deaths After Allogeneic Hematopoietic Cell Transplantation
- (2011) John R. Wingard et al. JOURNAL OF CLINICAL ONCOLOGY
- Interleukin-2 and Regulatory T Cells in Graft-versus-Host Disease
- (2011) John Koreth et al. NEW ENGLAND JOURNAL OF MEDICINE
- AZD9668, a neutrophil elastase inhibitor, plus ongoing budesonide/formoterol in patients with COPD
- (2011) Piotr Kuna et al. RESPIRATORY MEDICINE
- Consensus Conference on Clinical Practice in Chronic GVHD: Second-Line Treatment of Chronic Graft-versus-Host Disease
- (2010) Daniel Wolff et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Mesenchymal stem cell as salvage treatment for refractory chronic GVHD
- (2010) J Y Weng et al. BONE MARROW TRANSPLANTATION
- Interleukin-6 Modulates Graft-versus-Host Responses after Experimental Allogeneic Bone Marrow Transplantation
- (2010) I. Tawara et al. CLINICAL CANCER RESEARCH
- Life Expectancy in Patients Surviving More Than 5 Years After Hematopoietic Cell Transplantation
- (2010) Paul J. Martin et al. JOURNAL OF CLINICAL ONCOLOGY
- The S1P1-mTOR axis directs the reciprocal differentiation of TH1 and Treg cells
- (2010) Guangwei Liu et al. NATURE IMMUNOLOGY
- Sphingosine-1-phosphate and immune regulation: trafficking and beyond
- (2010) Hongbo Chi TRENDS IN PHARMACOLOGICAL SCIENCES
- Bronchiolitis Obliterans Syndrome After Allogeneic Hematopoietic Stem Cell Transplantation—An Increasingly Recognized Manifestation of Chronic Graft-versus-Host Disease
- (2009) Jason W. Chien et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- The role of B cells in the pathogenesis of graft-versus-host disease
- (2009) A. Shimabukuro-Vornhagen et al. BLOOD
- Altered B-cell homeostasis and excess BAFF in human chronic graft-versus-host disease
- (2009) S. Sarantopoulos et al. BLOOD
- Janus kinases in immune cell signaling
- (2009) Kamran Ghoreschi et al. IMMUNOLOGICAL REVIEWS
- Interleukin 17 acts in synergy with B cell–activating factor to influence B cell biology and the pathophysiology of systemic lupus erythematosus
- (2009) Agnès Doreau et al. NATURE IMMUNOLOGY
- Bortezomib Can Suppress Activation of Rapamycin-Resistant Memory T Cells Without Affecting Regulatory T-Cell Viability in Non-Human Primates
- (2009) Jung-Sik Kim et al. TRANSPLANTATION
- Murine Models of Chronic Graft-versus-Host Disease: Insights and Unresolved Issues
- (2008) Yu-Waye Chu et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started